Meeting Resources
DDW Tracks
Society
- DDW
- AASLD
- AGA
- ASGE
- SSAT
Visit DDW.org

Meeting Resources
DDW Tracks
Society
- DDW
- AASLD
- AGA
- ASGE
- SSAT
Visit DDW.org

ASGE

Happy Women in Medicine Month from DDW!

August 28, 2023

During Women in Medicine month, go back and rewatch some sessions from DDW 2023 on this important topic.

Preparation and Thinking Beyond Salary Are Key When Negotiating Your Contract

May 18, 2023

Clinicians hoping to renegotiate their contract should have data on the value they bring, including RVUs, quality metrics and patient satisfaction.

ASGE-Sponsored Guidelines Address 4 Key Questions Surrounding Flexible Endoscope Reprocessing

May 18, 2023

Recent multisociety guidelines find limited data behind some processes that have become standard practice.

It’s Time for Broadened Screening for Asymptomatic Patients at Risk for Barrett’s Esophagus and Esophageal Cancer

May 18, 2023

Chronic GERD is no longer a prerequisite to screen for Barrett’s esophagus—other risk factors may prove to be more valuable.

Miss a DDW® Session? Catch Up with DDW On Demand

May 8, 2023

Attendees will have access to all session captures 24 hours after the session ends. Continue to watch sessions on demand until May 17, 2024.

Endoscopic Approaches Should Take Precedence Over Surgery For Small Bowel Polyps

May 6, 2023

Hironori Yamamoto, MD, outlines five recommendations for managing patients with small bowel polyps.

Claim Your CME From DDW® 2023

May 6, 2023

DDW 2023 is certified for 624.5 AMA PRA Category 1 Credit(s)™. The CME claim site will be open through Oct. 31.

Making Sense of Pancreatic Cyst Guidelines

May 5, 2023

Despite their differences, pancreatic cyst guidelines published by different groups have key similarities. Vanessa Shami, MD, simplifies the guidelines for clinicians.

Welcome to DDW® 2023!

May 5, 2023

DDW 2023 is finally here! We’ve put together some important attendee tips. Be sure to also download the DDW Mobile App.

Novel Endoscopic Treatment Improves Glycemic Control and Eliminates Need for Insulin in Patients with Type 2 Diabetes

April 28, 2023

In a first-in-human study, 86% of patients were able to stop insulin after a single electroporation therapy combined with a GLP-1 receptor agonist.

Page1 Page2 Page3 … Page23

Discover

GET SOCIAL WITH #DDW2024

Twitter

Tweets by @ddwmeeting

Facebook

Facebook
Twitter
Youtube
Instagram
LinkedIn

Facebook
Twitter
Youtube
Instagram
LinkedIn

Privacy Policy
About DDW News
Visit DDW.org

Privacy Policy
About DDW News
Visit DDW.org

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.